Skip to main content
Clinical Trials/NL-OMON32078
NL-OMON32078
Completed
Phase 4

Ambulation performance in chronic stroke patients using an implanted drop foot stimulator - AMPECS

niversiteit Maastricht0 sites10 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
central motor neuron lesion
Sponsor
niversiteit Maastricht
Enrollment
10
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \* age \>\<\= 18 years;
  • \* first ever supratentorial stroke with persistent neurological deficit
  • \* post\-stroke time between 6 and 24 months;
  • \* Diagnosis and stroke severity
  • \* BARTHEL INDEX \* 15
  • \* clinically diagnosed central paresis of the leg;
  • \* drop foot, i.e. inability to achieve a normal heel strike during walking
  • \* balance and gait\-related criteria: subject is an outdoor walker:
  • \* Berg Balance score 48/56;
  • \* Rivermead mobility index 11/15\.

Exclusion Criteria

  • \* pacemaker
  • \* any medical condition that would exclude the use of a surgical procedure or anaesthetic
  • \* pregnancy
  • \* inability to read or understand Dutch or receptive aphasia?
  • \* no informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials